Jie Jiang, PhD, (Jie_Jiang@dfci.harvard.edu) is a cancer chemical biologist. Her studies focus on the development of small-molecule kinase inhibitors and targeted protein degraders as novel therapeutics to deliver new solutions for cancers that resist current therapies.